TY - JOUR
T1 - A single mutation (V64G) within the ring domain of Z attenuates junin virus
AU - Hallam, Steven J.
AU - Manning, John
AU - Maruyama, Junki
AU - Seregin, Alexey
AU - Huang, Cheng
AU - Walker, David H.
AU - de la Torre, Juan Carlos
AU - Paessler, Slobodan
N1 - Publisher Copyright:
© 2020 Hallam et al.
PY - 2020/9
Y1 - 2020/9
N2 - Junin virus (JUNV) is a New World arenavirus that is the causative agent of Argentine hemorrhagic fever (AHF). Candid#1 (Can) is a live-attenuated vaccine strain of JUNV that since its introduction has resulted in a marked decrease in AHF incidence within the endemic regions of the Pampas in Argentina. Originally, the viral determinants and mechanisms of Can attenuation were not well understood. Recent work has identified the glycoprotein as the major attenuating factor for Can. The establishment of attenuating strategies based on any of the other viral proteins, however, has not been pursued. Here, we document the role of Can Z resulting in incompatibilities with wild type JUNV that results in decreased growth in vitro. In addition, this incompatibility results in attenuation of the virus in the guinea pig model. Further, we identify a single mutation (V64G) in the Z protein that is able to confer this demonstrated attenuation. By establishing and characterizing a novel attenuation strategy for New World mammarenaviruses, we hope to aid future vaccine development for related emerging pathogens including Machupo virus (MACV), Guanarito virus (GTOV), and Sabia virus (SABV).
AB - Junin virus (JUNV) is a New World arenavirus that is the causative agent of Argentine hemorrhagic fever (AHF). Candid#1 (Can) is a live-attenuated vaccine strain of JUNV that since its introduction has resulted in a marked decrease in AHF incidence within the endemic regions of the Pampas in Argentina. Originally, the viral determinants and mechanisms of Can attenuation were not well understood. Recent work has identified the glycoprotein as the major attenuating factor for Can. The establishment of attenuating strategies based on any of the other viral proteins, however, has not been pursued. Here, we document the role of Can Z resulting in incompatibilities with wild type JUNV that results in decreased growth in vitro. In addition, this incompatibility results in attenuation of the virus in the guinea pig model. Further, we identify a single mutation (V64G) in the Z protein that is able to confer this demonstrated attenuation. By establishing and characterizing a novel attenuation strategy for New World mammarenaviruses, we hope to aid future vaccine development for related emerging pathogens including Machupo virus (MACV), Guanarito virus (GTOV), and Sabia virus (SABV).
UR - http://www.scopus.com/inward/record.url?scp=85092247584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092247584&partnerID=8YFLogxK
U2 - 10.1371/journal.pntd.0008555
DO - 10.1371/journal.pntd.0008555
M3 - Article
C2 - 32976538
AN - SCOPUS:85092247584
SN - 1935-2727
VL - 14
SP - 1
EP - 15
JO - PLoS neglected tropical diseases
JF - PLoS neglected tropical diseases
IS - 9
M1 - e0008555
ER -